Mayne Pharma competes against a broad array of international generic and specialty pharmaceutical companies operating within the dermatology, women's health, and oral drug delivery sectors. Key market competitors include major generic drug manufacturers, specialty branded dermatology providers, and contract development and manufacturing organizations (CDMOs) that vie for pharmacy distribution networks, insurance formulary placements, and clinical market share across the United States, Australia, and global healthcare markets.